Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.

Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.

<h4>Background</h4>The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can be profoundly reduced by cholesterol-lowering therapy, and current guidelines for FH advocate ambitious low-density lipoprotein cholesterol (LDL-C) goals. In the presen...

Full description

Bibliographic Details
Main Authors: Roeland Huijgen, Iris Kindt, Sjoerd B J Verhoeven, Eric J G Sijbrands, Maud N Vissers, John J P Kastelein, Barbara A Hutten
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-02-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20169164/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20169164/?tool=EBI

Similar Items